We are live on ! Find out more
AG

Algert Global Portfolio holdings

AUM $6.65B
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+13.2%
1 Year Est. Return
+53.68%
3 Year Est. Return
+140.8%
5 Year Est. Return
+204.57%
10 Year Est. Return
+1,528.09%
AUM
$4.77B
AUM Growth
+$731M
Cap. Flow
+$361M
Cap. Flow %
7.56%
Top 10 Hldgs %
5.9%
Holding
1,379
New
219
Increased
460
Reduced
380
Closed
212

Top Sells

Rank Stock Value
1
GMED icon
Globus Medical
GMED
+$11.3M
2
HURN icon
Huron Consulting
HURN
+$10.8M
3
FHI icon
Federated Hermes
FHI
+$10.5M
4
OUT icon
Outfront Media
OUT
+$10.4M
5
GFF icon
Griffon
GFF
+$10.3M

Sector Composition

Rank Sector Weight
1 Technology 16.45%
2 Industrials 15.7%
3 Financials 15.48%
4 Consumer Discretionary 12.41%
5 Healthcare 12.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVO icon
501
Mission Produce
AVO
$1.12B
$2.97M 0.06%
253,514
+1,730
+0.7% +$18.7K
WAL icon
502
Western Alliance Bancorporation
WAL
$9.11B
$2.96M 0.06%
38,023
EVR icon
503
Evercore
EVR
$13B
$2.96M 0.06%
10,959
-9,220
-46% -$2.03M
PODD icon
504
Insulet
PODD
$11B
$2.96M 0.06%
9,419
-1,031
-10% -$298K
PACS icon
505
PACS Group
PACS
$7.13B
$2.96M 0.06%
+228,734
New +$2.38M
AGIO icon
506
Agios Pharmaceuticals
AGIO
$2.14B
$2.95M 0.06%
88,830
+14,020
+19% +$425K
PRVA icon
507
Privia Health
PRVA
$3.2B
$2.95M 0.06%
128,338
+29,540
+30% +$684K
CBU icon
508
Community Bank
CBU
$3.53B
$2.92M 0.06%
51,328
-6,280
-11% -$349K
TNC icon
509
Tennant Co
TNC
$1.47B
$2.92M 0.06%
37,653
-5,965
-14% -$441K
MDGL icon
510
Madrigal Pharmaceuticals
MDGL
$12.4B
$2.88M 0.06%
9,530
-240
-2% -$71.5K
INSP icon
511
Inspire Medical Systems
INSP
$1.45B
$2.88M 0.06%
22,177
-37,643
-63% -$5.46M
CARG icon
512
CarGurus
CARG
$3.04B
$2.87M 0.06%
85,634
-25,850
-23% -$779K
CENTA icon
513
Central Garden & Pet Co Class A
CENTA
$2.39B
$2.86M 0.06%
91,430
-32,610
-26% -$1.02M
FOR icon
514
Forestar Group
FOR
$1.4B
$2.86M 0.06%
142,992
+46,460
+48% +$918K
LUMN icon
515
Lumen
LUMN
$6.9B
$2.86M 0.06%
652,424
-41,217
-6% -$160K
AMPH icon
516
Amphastar Pharmaceuticals
AMPH
$851M
$2.85M 0.06%
124,290
+106,990
+618% +$2.65M
SCL icon
517
Stepan Co
SCL
$1.34B
$2.84M 0.06%
52,048
+26,410
+103% +$1.39M
CLX icon
518
Clorox
CLX
$11.6B
$2.83M 0.06%
23,561
+19,811
+528% +$2.64M
CDE icon
519
Coeur Mining
CDE
$16.3B
$2.83M 0.06%
319,190
+116,480
+57% +$848K
HOMB icon
520
Home BancShares
HOMB
$6.09B
$2.82M 0.06%
99,085
CCK icon
521
Crown Holdings
CCK
$13B
$2.82M 0.06%
27,360
TCBI icon
522
Texas Capital Bancshares
TCBI
$4.49B
$2.82M 0.06%
35,460
+8,910
+34% +$639K
NXRT
523
NexPoint Residential Trust
NXRT
$664M
$2.81M 0.06%
84,265
+8,160
+11% +$289K
PSA icon
524
Public Storage
PSA
$54.7B
$2.81M 0.06%
9,566
-439
-4% -$130K
CSGS
525
DELISTED
CSG Systems International
CSGS
$2.8M 0.06%
+42,840
New +$2.67M

Similar funds

Algert Global's Q2 2025 Portfolio in Review

As of Q2 2025, Algert Global held 1,379 positions worth $4.77B, up 18% from $4.04B the previous quarter. Its ten largest holdings account for 5.9% of the portfolio.

Algert Global deployed $361M of net new capital in Q2 2025, opening 219 new positions and adding to 460 existing holdings. Its largest new stake was Millrose Properties Inc: 553,296 shares worth $15.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Huron Consulting, an estimated $10.8M trimmed.

  • Algert Global's largest Q2 2025 buy was Millrose Properties Inc: 553,296 shares worth $15.8M.
  • Algert Global added most to Albemarle in Q2 2025, an estimated $16.7M increase.
  • Algert Global's biggest Q2 2025 reduction was Huron Consulting, cutting an estimated $10.8M.
  • Algert Global fully exited Globus Medical in Q2 2025, selling an estimated $11.3M.
  • Algert Global's ten largest holdings make up 5.9% of its $4.77B portfolio in Q2 2025.
  • Algert Global opened 219 new positions and closed 212 in Q2 2025.
  • Algert Global's portfolio value rose 18% quarter-over-quarter to $4.77B.

Based on Algert Global's 13F filing for Q2 2025, filed 14 Aug 2025.